A study presented at the American Heart Association’s scientific meetings has raised concerns about the long-term use of melatonin, a commonly prescribed sleep aid in the UK. The findings suggest that those who use melatonin for extended periods may face a higher risk of heart failure, though the evidence requires careful interpretation.
Melatonin has been prescribed in the UK for nearly 20 years, with 2.5 million prescriptions issued in England just last year. It is a synthetic form of the natural hormone produced in the brain, known as the “hormone of darkness,” which helps regulate the sleep-wake cycle. Traditionally, melatonin has been considered safe for short-term use in adults and, under specialist supervision, for children with learning disabilities or ADHD.
The analysis examined electronic health records of about 130,000 adults experiencing sleep difficulties over five years. Half of the participants took melatonin, while the other half did not.
Melatonin is a synthetic version of the hormone naturally produced in the brain — the so-called “hormone of darkness” that regulates our sleep–wake cycle.
People who took melatonin for at least a year were roughly three times more likely to be hospitalised with heart failure than non-users.
Despite these concerning associations, the data is preliminary and requires further investigation before drawing firm conclusions about melatonin's safety in long-term use. The apparent link does not necessarily imply causation.
The current evidence suggests a potential link between long-term melatonin use and heart failure, but further detailed studies are necessary to clarify this relationship and assess safety.
Would you like the summary to be more technical or easier to understand?